Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Pradier

Showing results (111-120 of 163) with videos related to

Pageof 17
Sort By:
Sante Publique (Vandoeuvre-Les-Nancy, France)|December 20, 2011
[Innovating for an EHPAD of the future: the suggestions of professionals in the Alpes-Maritimes (France)]Corinne Grenier, François Gambarelli, Gérard Brami, et al.
Archives of Internal Medicine|March 15, 2006
Changes over time in risk of initial virological failure of combination antiretroviral therapy: a multicohort analysis, 1996 to 2002Fiona C Lampe, Jose M Gatell, Schlomo Staszewski, et al.
Family Medicine and Community Health|January 12, 2024
COVID-19 patient experiences in prehospital pathways: a processual approach using life-events calendar method and state sequence analysis shows detrimental delaysRomain Lutaud, Sebastien Cortaredona, Lea Delorme, et al.
Diabetes Care|December 6, 2008
Presence of the metabolic syndrome is not a better predictor of cardiovascular disease than the sum of its components in HIV-infected individuals: data collection on adverse events of anti-HIV drugs (D:A:D) studySigne W Worm, Caroline A Sabin, Peter Reiss, et al.
Journal of the International AIDS Society|March 7, 2018
Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D StudyCamilla I Hatleberg, Lene Ryom, Wafaa El-Sadr, et al.
AIDS (London, England)|October 4, 2008
HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignanciesAntonella d'Arminio Monforte, Donald Abrams, Christian Pradier, et al.
Open Forum Infectious Diseases|March 1, 2016
Antiretroviral Drugs and Risk of Chronic Alanine Aminotransferase Elevation in Human Immunodeficiency Virus (HIV)-Monoinfected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs StudyHelen Kovari, Caroline A Sabin, Bruno Ledergerber, et al.
Antiviral Therapy|April 27, 2016
Longitudinal analysis of the associations between antiretroviral therapy, viraemia and immunosuppression with lipid levels: the D:A:D studyDavid A Kamara, Colette Smith, Lene Ryom, et al.
Journal of the National Cancer Institute|December 22, 2017
Differences in Virological and Immunological Risk Factors for Non-Hodgkin and Hodgkin LymphomaLeah Shepherd, Lene Ryom, Matthew Law, et al.
AIDS (London, England)|May 11, 2010
Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D Study, Colette Smith, Caroline A Sabin, et al.
Pageof 17

Showing results (111-120 of 163) with videos related to

Sort By:
Pageof 17
Sante Publique (Vandoeuvre-Les-Nancy, France)|December 20, 2011
[Innovating for an EHPAD of the future: the suggestions of professionals in the Alpes-Maritimes (France)]Corinne Grenier, François Gambarelli, Gérard Brami, et al.
Archives of Internal Medicine|March 15, 2006
Changes over time in risk of initial virological failure of combination antiretroviral therapy: a multicohort analysis, 1996 to 2002Fiona C Lampe, Jose M Gatell, Schlomo Staszewski, et al.
Family Medicine and Community Health|January 12, 2024
COVID-19 patient experiences in prehospital pathways: a processual approach using life-events calendar method and state sequence analysis shows detrimental delaysRomain Lutaud, Sebastien Cortaredona, Lea Delorme, et al.
Diabetes Care|December 6, 2008
Presence of the metabolic syndrome is not a better predictor of cardiovascular disease than the sum of its components in HIV-infected individuals: data collection on adverse events of anti-HIV drugs (D:A:D) studySigne W Worm, Caroline A Sabin, Peter Reiss, et al.
Journal of the International AIDS Society|March 7, 2018
Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D StudyCamilla I Hatleberg, Lene Ryom, Wafaa El-Sadr, et al.
AIDS (London, England)|October 4, 2008
HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignanciesAntonella d'Arminio Monforte, Donald Abrams, Christian Pradier, et al.
Open Forum Infectious Diseases|March 1, 2016
Antiretroviral Drugs and Risk of Chronic Alanine Aminotransferase Elevation in Human Immunodeficiency Virus (HIV)-Monoinfected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs StudyHelen Kovari, Caroline A Sabin, Bruno Ledergerber, et al.
Antiviral Therapy|April 27, 2016
Longitudinal analysis of the associations between antiretroviral therapy, viraemia and immunosuppression with lipid levels: the D:A:D studyDavid A Kamara, Colette Smith, Lene Ryom, et al.
Journal of the National Cancer Institute|December 22, 2017
Differences in Virological and Immunological Risk Factors for Non-Hodgkin and Hodgkin LymphomaLeah Shepherd, Lene Ryom, Matthew Law, et al.
AIDS (London, England)|May 11, 2010
Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D Study, Colette Smith, Caroline A Sabin, et al.
Pageof 17